Home > Publications database > Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels. > print

001     288539
005     20241127133857.0
024 7 _ |a 10.1007/s00520-024-08373-x
|2 doi
024 7 _ |a pmid:38386101
|2 pmid
024 7 _ |a 0941-4355
|2 ISSN
024 7 _ |a 1433-7339
|2 ISSN
037 _ _ |a DKFZ-2024-00403
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wang, Yan
|0 0000-0002-3136-3109
|b 0
245 _ _ |a Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels.
260 _ _ |a New York,NY
|c 2024
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1708700049_2947
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a This paper aims to provide a comprehensive understanding of the need for continued development of symptom monitoring (SM) implementation, utilization, and data usage at the macro-, meso-, and micro-levels.Discussions from a patient-reported SM workshop at the MASCC/ISSO 2022 annual meeting were analyzed using a macro-meso-micro analytical framework of cancer care delivery. The workshop categories 'initiation and implementation, barriers to adoption and utilization, and data usage' were integrated for each level.At the macro-level, policy development could encourage data sharing and international collaboration, including the exchange of SM methods, supportive care models, and self-management modules. At the meso-level, institutions should adjust clinical workflow and service delivery and promote a thorough technical and clinical integration of SM. At the micro-level, SM should be individualized, with timely feedback for patients, and should foster trust and understanding of AI decision support tools amongst clinicians to improve supportive care.The workshop reached a consensus among international experts on providing guidance on SM implementation, utilization, and (big) data usage pathways in cancer survivors across the cancer continuum and on macro-meso-micro levels.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Real-world data
|2 Other
650 _ 7 |a Supportive care
|2 Other
650 _ 7 |a Symptom monitoring
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Cancer Survivors
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Consensus
|2 MeSH
650 _ 2 |a Information Dissemination
|2 MeSH
650 _ 2 |a Patient Reported Outcome Measures
|2 MeSH
700 1 _ |a Allsop, Matthew J
|0 0000-0002-7399-0194
|b 1
700 1 _ |a Epstein, Joel B
|b 2
700 1 _ |a Howell, Doris
|0 0000-0002-0683-8715
|b 3
700 1 _ |a Rapoport, Bernardo L
|0 0000-0001-7610-3653
|b 4
700 1 _ |a Schofield, Penelope
|0 0000-0001-9495-9543
|b 5
700 1 _ |a Van Sebille, Ysabella
|0 0000-0002-5803-3230
|b 6
700 1 _ |a Thong, Melissa
|0 P:(DE-He78)24fe6057396bec79d2638615b12eb989
|b 7
|u dkfz
700 1 _ |a Walraven, Iris
|0 0000-0002-6083-730X
|b 8
700 1 _ |a Ryan Wolf, Julie
|0 0000-0002-0592-7820
|b 9
700 1 _ |a van den Hurk, Corina J G
|0 0000-0002-7802-1034
|b 10
773 _ _ |a 10.1007/s00520-024-08373-x
|g Vol. 32, no. 3, p. 182
|0 PERI:(DE-600)1463166-0
|n 3
|p 182
|t Supportive care in cancer
|v 32
|y 2024
|x 0941-4355
856 4 _ |u https://inrepo02.dkfz.de/record/288539/files/s00520-024-08373-x.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288539/files/s00520-024-08373-x.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:288539
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)24fe6057396bec79d2638615b12eb989
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SUPPORT CARE CANCER : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l C071 Cancer Survivorship
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21